These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34375670)

  • 1. PKCι regulates the expression of PDL1 through multiple pathways to modulate immune suppression of pancreatic cancer cells.
    Zhang H; Zhu Y; Wang J; Weng S; Zuo F; Li C; Zhu T
    Cell Signal; 2021 Oct; 86():110115. PubMed ID: 34375670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis.
    Wang P; Wei D; Zhang H; Chen J; Zhang D; Ganapathy S; Isakson P; Chen C; Zhu T
    Oncotarget; 2018 Aug; 9(67):32736-32750. PubMed ID: 30214681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
    Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKCι Is a Promising Prognosis Biomarker and Therapeutic Target for Pancreatic Cancer.
    Abdelatty A; Fang D; Wei G; Wu F; Zhang C; Xu H; Yao C; Wang Y; Xia H
    Pathobiology; 2022; 89(6):370-381. PubMed ID: 35785767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription factor Sp1 is upregulated by PKCι to drive the expression of YAP1 during pancreatic carcinogenesis.
    Yang J; Wang J; Zhang H; Li C; Chen C; Zhu T
    Carcinogenesis; 2021 Apr; 42(3):344-356. PubMed ID: 33146712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis.
    Scotti ML; Bamlet WR; Smyrk TC; Fields AP; Murray NR
    Cancer Res; 2010 Mar; 70(5):2064-74. PubMed ID: 20179210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mu-KRAS attenuates Hippo signaling pathway through PKCι to sustain the growth of pancreatic cancer.
    Wang P; Zhang H; Yang J; Li Z; Wang Y; Leng X; Ganapathy S; Isakson P; Chen C; Zhu T
    J Cell Physiol; 2020 Jan; 235(1):408-420. PubMed ID: 31230347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Effects of PKCι on Anti-tumor Activity of Cytokine-induced Killer Cells Against Pancreatic Cancer Cells and the Possible Underlying Mechanisms].
    Zhang HM; Wang YR; Yang JH; Leng XH; Wang PP; Li ZX; Zhu TB
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 50(6):821-826. PubMed ID: 31880112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion.
    Yang Y; Stang A; Schweickert PG; Lanman NA; Paul EN; Monia BP; Revenko AS; Palumbo JS; Mullins ES; Elzey BD; Janssen EM; Konieczny SF; Flick MJ
    Cancer Res; 2019 Jul; 79(13):3417-3430. PubMed ID: 31048498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANGPTL4 accelerates KRAS
    Yan HH; Jung KH; Lee JE; Son MK; Fang Z; Park JH; Kim SJ; Kim JY; Lim JH; Hong SS
    Cancer Lett; 2021 Oct; 519():185-198. PubMed ID: 34311032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric switch-receptor PD1-DAP10-41BB augments NK92-cell activation and killing for human lung Cancer H1299 Cell.
    Zhi L; Yin M; Su X; Zhang Z; Lu H; Li M; Guo C; Niu Z; Zhang X; Zhu W
    Biochem Biophys Res Commun; 2022 Apr; 600():94-100. PubMed ID: 35217362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia.
    Xu LJ; Ma Q; Zhu J; Li J; Xue BX; Gao J; Sun CY; Zang YC; Zhou YB; Yang DR; Shan YX
    Mol Med Rep; 2018 Jun; 17(6):8111-8120. PubMed ID: 29693186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer.
    Li C; Cui L; Yang L; Wang B; Zhuo Y; Zhang L; Wang X; Zhang Q; Zhang S
    Pancreas; 2020 Jan; 49(1):120-127. PubMed ID: 31856087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKCι induces differential phosphorylation of STAT3 to modify STAT3-related signaling pathways in pancreatic cancer cells.
    Wang J; Weng S; Zhu Y; Chen H; Pan J; Qiu S; Liu Y; Wei D; Zhu T
    J Cell Commun Signal; 2023 Dec; 17(4):1417-1433. PubMed ID: 37548811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients.
    Lim SA; Kim J; Jeon S; Shin MH; Kwon J; Kim TJ; Im K; Han Y; Kwon W; Kim SW; Yee C; Kim SJ; Jang JY; Lee KM
    Front Immunol; 2019; 10():496. PubMed ID: 31024520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-128 Regulates Tumor Cell CD47 Expression and Promotes Anti-tumor Immunity in Pancreatic Cancer.
    Xi Q; Chen Y; Yang GZ; Zhang JY; Zhang LJ; Guo XD; Zhao JY; Xue ZY; Li Y; Zhang R
    Front Immunol; 2020; 11():890. PubMed ID: 32536914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells.
    Yu Q; Newsome RC; Beveridge M; Hernandez MC; Gharaibeh RZ; Jobin C; Thomas RM
    Gut Microbes; 2022; 14(1):2112881. PubMed ID: 35980869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribonucleoprotein HNRNPA2B1 interacts with and regulates oncogenic KRAS in pancreatic ductal adenocarcinoma cells.
    Barceló C; Etchin J; Mansour MR; Sanda T; Ginesta MM; Sanchez-Arévalo Lobo VJ; Real FX; Capellà G; Estanyol JM; Jaumot M; Look AT; Agell N
    Gastroenterology; 2014 Oct; 147(4):882-892.e8. PubMed ID: 24998203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic tumors and immature immunosuppressive myeloid cells in blood and spleen: role of inhibitory co-stimulatory molecules PDL1 and CTLA4. An in vivo and in vitro study.
    Basso D; Fogar P; Falconi M; Fadi E; Sperti C; Frasson C; Greco E; Tamburrino D; Teolato S; Moz S; Bozzato D; Pelloso M; Padoan A; De Franchis G; Gnatta E; Facco M; Zambon CF; Navaglia F; Pasquali C; Basso G; Semenzato G; Pedrazzoli S; Pederzoli P; Plebani M
    PLoS One; 2013; 8(1):e54824. PubMed ID: 23359812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling.
    Gruber R; Panayiotou R; Nye E; Spencer-Dene B; Stamp G; Behrens A
    Gastroenterology; 2016 Sep; 151(3):526-39. PubMed ID: 27215660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.